These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 828465)

  • 1. Disposition of narcotics and narcotic antagonists.
    Inturrisi CE
    Ann N Y Acad Sci; 1976; 281():273-87. PubMed ID: 828465
    [No Abstract]   [Full Text] [Related]  

  • 2. Interactions of narcotics, narcotic antagonists, and ethanol during acute, chronic, and withdrawal states.
    Ho AK; Chen RC
    Ann N Y Acad Sci; 1976; 281():297-310. PubMed ID: 1071365
    [No Abstract]   [Full Text] [Related]  

  • 3. Evaluation of narcotic and narcotic antagonist interactions in primates.
    Killam KF; Brocco MJ; Robinson CA
    Ann N Y Acad Sci; 1976; 281():331-5. PubMed ID: 828467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Possible influence of opioid normetabolites on the onset, magnitude and quality of the opioid abstinence syndrome.
    Fraser HF; Gorodetzky CW; Kay DC; Yeh SY
    Drug Alcohol Depend; 1980 Apr; 5(4):255-72. PubMed ID: 6989579
    [No Abstract]   [Full Text] [Related]  

  • 5. Acute effects of ethanol on hepatic uptake and distribution of narcotics in the isolated perfused rabbit liver.
    Kreek MJ; Rothschild MA; Oratz M; Mongelli J; Handley AC
    Hepatology; 1981; 1(5):419-23. PubMed ID: 7308987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacology of LAAM.
    Archer S
    NIDA Res Monogr; 1976 Jul; (8):15-28. PubMed ID: 825782
    [No Abstract]   [Full Text] [Related]  

  • 7. Disposition of acetylmethadol in relation to pharmacological activity. 1975 [proceedings].
    Kaiki RF; Inturrisi C
    NIDA Res Monogr; 1976 Jul; (8):80-1. PubMed ID: 995183
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical pharmacokinetics of narcotic agonist-antagonist drugs.
    Bullingham RE; McQuay HJ; Moore RA
    Clin Pharmacokinet; 1983; 8(4):332-43. PubMed ID: 6352139
    [No Abstract]   [Full Text] [Related]  

  • 9. Discriminative stimulus effects of l-alpha-acetylmethadol (LAAM), buprenorphine and methadone in morphine-treated rhesus monkeys.
    Brandt MR; Cabansag SR; France CP
    J Pharmacol Exp Ther; 1997 Aug; 282(2):574-84. PubMed ID: 9262317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physiological disposition and biotransformation of l-alpha-[2-3H]acetylmethadol (LAAM) in acutely and chronically treated monkeys.
    Misra AL; Mulé SJ; Bloch R; Bates TR
    J Pharmacol Exp Ther; 1978 Aug; 206(2):475-91. PubMed ID: 98628
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical treatment of opioid addiction and dependence.
    Ling W; Rawson RA; Compton M
    Methods Mol Med; 2003; 84():285-95. PubMed ID: 12703332
    [No Abstract]   [Full Text] [Related]  

  • 12. Maintenance therapy for opioid addiction with methadone, LAAM and buprenorphine: the Emperor's New Clothes Phenomenon.
    Stimmel B
    J Addict Dis; 2001; 20(4):1-5. PubMed ID: 11760922
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacokinetics and metabolism of l-alpha-[O,O'-3H2]-acetyl normethadol (nor-LAAM), the active metabolite of LAAM, in acutely and chronically treated rhesus monkeys.
    Misra AL; Bartolomeo JG; Bloch R; Mulé SJ; Bates TR
    J Pharmacol Exp Ther; 1980 Sep; 214(3):599-607. PubMed ID: 6772759
    [No Abstract]   [Full Text] [Related]  

  • 14. Metabolism of methadone and levo-alpha-acetylmethadol (LAAM) by human intestinal cytochrome P450 3A4 (CYP3A4): potential contribution of intestinal metabolism to presystemic clearance and bioactivation.
    Oda Y; Kharasch ED
    J Pharmacol Exp Ther; 2001 Sep; 298(3):1021-32. PubMed ID: 11504799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relative potency of levo-alpha-acetylmethadol and methadone in humans under acute dosing conditions.
    Eissenberg T; Stitzer ML; Bigelow GE; Buchhalter AR; Walsh SL
    J Pharmacol Exp Ther; 1999 May; 289(2):936-45. PubMed ID: 10215673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disposition of acetylmethadol in relation to pharmacologic action.
    Kaiko RF; Inturrisi CE
    Clin Pharmacol Ther; 1975 Jul; 18(1):96-103. PubMed ID: 238782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative study of the electroencephalographic and behavioral effects of l-alpha-acetylmethadol (LAAM), two of its metabolites and morphine and methadone in the rat.
    Lukas SE; Moreton JE; Khazan N
    J Pharmacol Exp Ther; 1980 Nov; 215(2):382-9. PubMed ID: 7441502
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacology of l-alpha-acetylmethadol (LAAM) in subhuman primates.
    Mulé SJ; Misra AL
    Ann N Y Acad Sci; 1978; 311():199-213. PubMed ID: 105659
    [No Abstract]   [Full Text] [Related]  

  • 19. General cardiovascular pharmacology of 1-alpha-acetylmethadol (LAAM).
    Stickney JL; Eikenburg DC; Keedy JD
    NIDA Res Monogr; 1979; 27():422-8. PubMed ID: 121363
    [No Abstract]   [Full Text] [Related]  

  • 20. Metabolism and disposition of l-alpha-acetylmethadol in the rat.
    Henderson GL; North-Root H; Kuttab SH
    Drug Metab Dispos; 1977; 5(4):321-8. PubMed ID: 19211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.